000			02031 a2200577 4500
005			20250513203612.0
264		0	_c20000413
008			200004s 0 0 eng d
022			_a0264-410X
024	7		_a10.1016/s0264-410x(99)00527-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aGonzalez, I M
245	0	0	_aEvaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults. _h[electronic resource]
260			_bVaccine _cMar 2000
300			_a1763-72 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Viral _xblood
650	0	4	_aAntibody Formation _xdrug effects
650	0	4	_aDose-Response Relationship, Immunologic
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHN Protein
650	0	4	_aHumans
650	0	4	_aImmunity, Mucosal _xdrug effects
650	0	4	_aImmunoglobulin A _xblood
650	0	4	_aImmunoglobulin G _xblood
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNasal Mucosa _ximmunology
650	0	4	_aRegression Analysis
650	0	4	_aRespiratory Syncytial Virus, Human _ximmunology
650	0	4	_aVaccines, Attenuated _xadministration & dosage
650	0	4	_aViral Envelope Proteins _xadministration & dosage
650	0	4	_aViral Proteins _xadministration & dosage
650	0	4	_aViral Vaccines _xadministration & dosage
700	1		_aKarron, R A
700	1		_aEichelberger, M
700	1		_aWalsh, E E
700	1		_aDelagarza, V W
700	1		_aBennett, R
700	1		_aChanock, R M
700	1		_aMurphy, B R
700	1		_aClements-Mann, M L
700	1		_aFalsey, A R
773	0		_tVaccine _gvol. 18 _gno. 17 _gp. 1763-72
856	4	0	_uhttps://doi.org/10.1016/s0264-410x(99)00527-7 _zAvailable from publisher's website
999			_c10653429 _d10653429